Safety Evaluation of Recombinant Human Interleukin-4 I. Preclinical Studies

Author： Leach M.W.   Snyder E.A.   Sinha D.P.   Rosenblum I.Y.  

Publisher： Academic Press

ISSN： 1521-6616

Source： Clinical Immunology, Vol.83, Iss.1, 1997-04, pp. : 8-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety Evaluation of Recombinant Human Interleukin-4 II. Clinical Studies

By Leach M.W.   Rybak M.E.   Rosenblum I.Y.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 12-14

Academic Press

Access to resources Recommend Favorite

Immunogenicity of Recombinant Human Interleukin-3

By Gunn H.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 5-7

Academic Press

Access to resources Recommend Favorite

Preclinical Safety Assessment of the Recombinant TNF Receptor-Immunoglobulin Fusion Protein

By Winter M.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 21-24

Academic Press

Access to resources Recommend Favorite

Phase I Safety, Tolerability, and Pharmacokinetic Study of Recombinant Human Mannan-Binding Lectin

By Petersen Kenneth   Matthiesen Finn   Agger Teit   Kongerslev Leif   Thiel Steffen   Cornelissen Karen   Axelsen Mads  

Journal of Clinical Immunology, Vol. 26, Iss. 5, 2006-09 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of Murine Experimental Autoimmune Orchitis by Recombinant Human Interleukin-6

By Li L.   Itoh M.   Ablake M.   Macrì B.   Bendtzen K.   Nicoletti F.  

Clinical Immunology, Vol. 102, Iss. 2, 2002-02 ,pp. : 135-137

Academic Press

Access to resources Recommend Favorite